Marketed in 54 countries across Europe, the Americas, Asia-Pacific, and parts of North Africa, Actos is a globally distributed brand of pioglitazone hydrochloride, classified within the category of hypoglycemic drugs used in diabetes. Its broad regulatory footprint means travellers, expatriates, and family members managing long-term diabetes therapy frequently encounter the same medication in unfamiliar pharmacies abroad.
Actos is prescribed in the management of type 2 diabetes mellitus, generally as part of a longer-term plan that also addresses lifestyle factors and may sit alongside other glucose-lowering medications. The structured indication list further down this page details the registered uses recognised by national regulators in the markets where Actos is sold.
Because Actos is registered in so many countries — among them Canada, Australia, China, Egypt, Argentina, and the Czech Republic — international readers often see it under the Actos name in one country and under a different commercial label or as a generic in the next. Brand naming conventions, packaging, and prescription pathways vary considerably between regulatory regimes, and a pharmacist working in the destination country is usually the most efficient person to confirm whether a pioglitazone-containing product is the appropriate equivalent of what was originally prescribed back home.
Other medications used in the management of type 2 diabetes — both within the same hypoglycemic class and in adjacent classes — circulate worldwide under a wide range of molecules and brand names, and not all are interchangeable with pioglitazone. Decisions about starting, stopping, or switching any diabetes medication belong with a clinician who knows the patient's full history, and a local pharmacist can support that conversation by clarifying what is available regionally.
3 years.
26/05/2016
Takeda Pharma A/S
Dybendal Alle 10,
DK-2630 Taastrup
Denmark
This medicinal product does not require any special storage conditions.
Aluminium/aluminium blisters, packs of 14, 28, 30, 50, 56, 84, 90, 98, 112 and 196 tablets.
Not all pack sizes may be marketed.
EU/1/00/150/001
EU/1/00/150/002
EU/1/00/150/003
EU/1/00/150/004
EU/1/00/150/005
EU/1/00/150/006
EU/1/00/150/007
EU/1/00/150/008
EU/1/00/150/009
EU/1/00/150/010
EU/1/00/150/011
EU/1/00/150/012
EU/1/00/150/013
EU/1/00/150/014
EU/1/00/150/015
EU/1/00/150/016
EU/1/00/150/017
EU/1/00/150/018
EU/1/00/150/019
EU/1/00/150/020
EU/1/00/150/021
EU/1/00/150/022
EU/1/00/150/023
EU/1/00/150/024
EU/1/00/150/025
EU/1/00/150/026
EU/1/00/150/027
EU/1/00/150/028
EU/1/00/150/029
EU/1/00/150/030
No special requirements for disposal.
Date of first authorisation: 13/10/2000
Date of latest renewal: 31/08/2010
Actos is prescribed in the management of type 2 diabetes mellitus. It belongs to the category of hypoglycemic drugs used in diabetes, meaning its therapeutic role is to support blood-glucose control as part of a longer-term treatment plan that typically also includes lifestyle measures and, in many cases, other glucose-lowering medications. The structured indication block on this page lists the registered uses recognised across the markets where Actos is sold.
Actos contains pioglitazone hydrochloride, classified within the hypoglycemic category of medications used in diabetes. Pioglitazone is the same active ingredient regardless of brand: internationally, it circulates under the Actos label in some markets and under other commercial names or as a generic in others, particularly in countries where the original patent has expired and additional manufacturers produce pioglitazone products.
Actos is registered in 54 countries spanning multiple regions, with examples including Canada, Australia, China, Egypt, Argentina, Belgium, and the Czech Republic. The full country list is shown in the structured section below this introduction. If your country is not represented, a local pharmacist can usually confirm whether pioglitazone is available in that market under a different brand name or as a generic preparation.
Pioglitazone is sold under several brand names internationally, particularly in markets where the original patent has expired and generic manufacturers have entered. Other medications used in the broader management of type 2 diabetes also exist in adjacent pharmacological classes, although they are not freely interchangeable with pioglitazone. To identify a local pioglitazone-containing product, search the active ingredient on Pill2Trip or ask a pharmacist in your country.
Yes. Actos is a prescription medication, and treatment for type 2 diabetes is calibrated to each patient's individual circumstances, including concurrent medications and overall clinical picture. This is especially relevant for travellers and people relocating between countries, since prescription rules, branded packaging, and available generics can differ significantly across regulatory regimes. Any decision to start, stop, or substitute pioglitazone should be made together with a healthcare provider.
